Esteve J - Search Results

1

Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.

Banús-Mulet A, Etxabe A, Cornet-Masana JM, Torrente MÁ, Lara-Castillo MC, Palomo L, Nomdedeu M, Díaz-Beyá M, Solé F, Nomdedeu B, Esteve J, Risueño RM. Banús-Mulet A, et al. Among authors: esteve j. Sci Rep. 2018 Sep 17;8(1):13883. doi: 10.1038/s41598-018-32306-4. Sci Rep. 2018. PMID: 30224768 Free PMC article.

2

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

Rozman M, Camós M, Colomer D, Villamor N, Esteve J, Costa D, Carrió A, Aymerich M, Aguilar JL, Domingo A, Solé F, Gomis F, Florensa L, Montserrat E, Campo E. Rozman M, et al. Among authors: esteve j. Genes Chromosomes Cancer. 2004 Jun;40(2):140-5. doi: 10.1002/gcc.20022. Genes Chromosomes Cancer. 2004. PMID: 15101047

3

Dermatomyositis associated with acute myeloid leukaemia: a paraneoplastic association or a drug-induced phenomenon?

Carrera C, Cibeira MT, Iranzo P, Esteve J, Nomdedeu B, Herrero C. Carrera C, et al. Among authors: esteve j. Acta Derm Venereol. 2004;84(5):401-2. Acta Derm Venereol. 2004. PMID: 15503359 No abstract available.

4

Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.

Madrigal I, Carrió A, Gómez C, Rozman M, Esteve J, Nomdedeu B, Campo E, Costa D. Madrigal I, et al. Among authors: esteve j. Cancer Genet Cytogenet. 2006 Oct 15;170(2):115-20. doi: 10.1016/j.cancergencyto.2006.05.007. Cancer Genet Cytogenet. 2006. PMID: 17011981

5

The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status.

Díaz-Beyá M, Rozman M, Pratcorona M, Torrebadell M, Camós M, Aguilar JL, Esteve J. Díaz-Beyá M, et al. Among authors: esteve j. Blood. 2010 Dec 23;116(26):6147-8. doi: 10.1182/blood-2010-09-307314. Blood. 2010. PMID: 21183700 Free article. No abstract available.

6

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation.

Nomdedeu M, Maffioli M, Calvo X, Martínez-Trillos A, Baumann T, Díaz-Beyá M, Aguilar JL, Rozman M, Costa D, Esteve J, Cervantes F, Colomer D, Nomdedeu B. Nomdedeu M, et al. Among authors: esteve j. Leuk Res. 2011 Sep;35(9):1276-8. doi: 10.1016/j.leukres.2011.06.008. Epub 2011 Jul 20. Leuk Res. 2011. PMID: 21764129 No abstract available.

7

Refining the diagnosis and prognostic categorization of acute myeloid leukemia patients with an integrated use of cytogenetic and molecular studies.

Costa D, Vidal A, Carrió A, Muñoz C, Arias A, Gómez C, Berneaga D, Colomer D, Rozman M, Pratcorona M, Torrebadell M, Díaz-Beyá M, Esteve J, Campo E. Costa D, et al. Among authors: esteve j. Acta Haematol. 2013;129(2):65-71. doi: 10.1159/000343616. Epub 2012 Nov 15. Acta Haematol. 2013. PMID: 23154527

8

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.

Pratcorona M, Brunet S, Nomdedéu J, Ribera JM, Tormo M, Duarte R, Escoda L, Guàrdia R, Queipo de Llano MP, Salamero O, Bargay J, Pedro C, Martí JM, Torrebadell M, Díaz-Beyá M, Camós M, Colomer D, Hoyos M, Sierra J, Esteve J; Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas. Pratcorona M, et al. Among authors: esteve j. Blood. 2013 Apr 4;121(14):2734-8. doi: 10.1182/blood-2012-06-431122. Epub 2013 Feb 1. Blood. 2013. PMID: 23377436 Free article.

9

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.

Rozman M, Navarro JT, Arenillas L, Aventín A, Giménez T, Alonso E, Perea G, Camós M, Navarrete M, Tuset E, Florensa L, Millá F, Nomdedéu J, de la Banda E, Díaz-Beyá M, Pratcorona M, Garrido A, Navarro B, Brunet S, Sierra J, Esteve J; Grup Català de Citologia Hematològica and Spanish CETLAM Group (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas). Rozman M, et al. Among authors: esteve j. Ann Hematol. 2014 Oct;93(10):1695-703. doi: 10.1007/s00277-014-2100-6. Epub 2014 May 14. Ann Hematol. 2014. PMID: 24824767

10

High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.

Calvo X, Nomdedeu M, Navarro A, Tejero R, Costa D, Muñoz C, Pereira A, Peña O, Risueño RM, Monzó M, Esteve J, Nomdedeu B. Calvo X, et al. Among authors: esteve j. Leuk Res. 2014 Aug;38(8):874-81. doi: 10.1016/j.leukres.2014.04.015. Epub 2014 May 12. Leuk Res. 2014. PMID: 24880536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters